Apolipoprotein A-I directly interacts with amyloid precursor protein and inhibits A beta aggregation and toxicity
about
The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptideUptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood-brain barrier modelImpact of apolipoprotein E on Alzheimer's diseaseApoE promotes the proteolytic degradation of AbetaApolipoprotein A-I: insights from redox proteomics for its role in neurodegenerationCerebrospinal Fluid Particles in Alzheimer Disease and Parkinson DiseaseAssociation of plasma Aß peptides with blood pressure in the elderlyATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice.Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects.High-density lipoprotein modulates thrombosis by preventing von Willebrand factor self-association and subsequent platelet adhesion.Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP/PS1DeltaE9 miceOverexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease.Novel N-terminal mutation of human apolipoprotein A-I reduces self-association and impairs LCAT activationThe role of apolipoprotein E in Alzheimer's disease.HDL and cognition in neurodegenerative disorders.Apolipoproteins in the brain: implications for neurological and psychiatric disorders.Physiopathological modulators of amyloid aggregation and novel pharmacological approaches in Alzheimer's disease.Function and comorbidities of apolipoprotein e in Alzheimer's disease.Apolipoprotein E promotes β-amyloid trafficking and degradation by modulating microglial cholesterol levels.Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease.Expression profiling in APP23 mouse brain: inhibition of Abeta amyloidosis and inflammation in response to LXR agonist treatmentAbca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegenerationOverexpression of Hsp27 ameliorates symptoms of Alzheimer's disease in APP/PS1 mice.Memory deficits in APP23/Abca1+/- mice correlate with the level of Aβ oligomersPharmacotherapy of agitation and psychotic symptoms in Alzheimer's disease.ATP-binding cassette transporter A1: from metabolism to neurodegeneration.Direct High Affinity Interaction between Aβ42 and GSK3α Stimulates Hyperphosphorylation of Tau. A New Molecular Link in Alzheimer's Disease?Advances in high-density lipoprotein physiology: surprises, overturns, and promises.Apolipoprotein A-I: A Molecule of Diverse Function.Cross-interactions between the Alzheimer Disease Amyloid-β Peptide and Other Amyloid Proteins: A Further Aspect of the Amyloid Cascade Hypothesis.Proton pump inhibitor lansoprazole is a nuclear liver X receptor agonist.Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly.Syphilitic dementia and lipid metabolism.Apolipoprotein e: essential catalyst of the Alzheimer amyloid cascade.Identification of hepatic copper-binding proteins from tilapia by column chromatography with proteomic approaches.Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice.SR-BI Mediated Transcytosis of HDL in Brain Microvascular Endothelial Cells Is Independent of Caveolin, Clathrin, and PDZK1.
P2860
Q21090025-D1BDE7F5-BD37-41BF-97E0-A133F723E909Q24292859-EA60B335-916B-4E00-A779-33F1B306D74CQ24567759-1D21048F-A630-47C0-95B1-1013E626AEC6Q24651102-3263E092-B6CD-4029-B9D4-8CAC8C19D117Q27026686-C77B1971-54C2-4CF4-A55F-10BE30348F59Q27314618-1A8B1932-54A0-4478-8942-8FBF8271260FQ28740991-B502751F-8A86-472D-ACEC-B306EF80FA7AQ30497102-80261493-2D36-4502-8613-654EF56F8157Q33237201-0D9E6AC0-4ECC-4E16-B949-2A89791F9E99Q33427429-5CFF213A-4723-46CC-B7BA-DCEDD2E5B43CQ33666765-9717E048-773A-4C86-AE88-E075D00E4785Q34299304-F65684F2-705E-485E-894E-59453AC1457CQ34299310-BEDE352B-9C79-4220-B6F0-4A8C3E45AD5CQ34395097-FCE5DA13-02F9-4E68-8152-4961B2343B50Q34603092-E80CD95F-7E2D-48A8-A3DE-A601B506F92CQ34614842-35F46763-D225-4154-BEE3-4186785AE69BQ34680878-FEB3A6A6-0B92-4AA3-84C8-8A0758D26A37Q34721350-DE5BCD93-83CA-49B2-8278-DDF19665D6BFQ34951817-CD805947-AD44-4D49-9580-A6589A9E14A7Q35694025-6D491755-C1AE-442D-B7D1-AF03249A7435Q36256076-740C343B-E96C-488D-A625-95782C00DF31Q36407043-5606A5A1-14D2-4620-ACDC-927FA71FC740Q36822983-17B098A5-4328-43E3-964B-2C647243E190Q36946758-9F73EC76-6719-422B-873C-2D9EAC8BEB70Q37017266-B02FFBCA-B7C7-4F23-B8D3-D539F64D4D2EQ37213608-C4CC76D0-A983-4886-A5F8-C91B58197648Q37225388-FA2034FC-968C-459E-A5D4-D276E2F2BC43Q37610267-3A1DBEBA-D92B-43C2-BFC1-C5B9037A5067Q38213077-211533D5-B88D-4837-B21F-AB053D862B08Q38556871-1AE18384-5019-4F6A-A5F5-D75A6BA33BA4Q38623588-2DAF0EA1-153E-4654-9450-01F7E7EB603BQ38844884-E5BF3BBD-CEED-4BEC-BAF1-F59B36F3D52EQ38871578-FCE1D151-4CB1-4F32-ADB0-7D4D07A1B08CQ39495324-BEA81D57-712A-43A7-ABF7-DBEB09DEC10CQ40401981-A95CDBE5-8E4D-4C87-AE68-8D5C0394CF41Q40613739-7A665AC1-7187-4278-A99F-DE7683464270Q42247507-F4AC6B64-103F-48AC-8669-B79D4705809AQ42717469-E8486E78-DE3A-4218-AF50-5EECAB647B89Q46738149-5395F286-0816-445E-B246-57B69BB7B68EQ47106019-98E62433-8467-4118-8FD7-3FD3798BC854
P2860
Apolipoprotein A-I directly interacts with amyloid precursor protein and inhibits A beta aggregation and toxicity
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Apolipoprotein A-I directly in ...... beta aggregation and toxicity
@ast
Apolipoprotein A-I directly in ...... beta aggregation and toxicity
@en
Apolipoprotein A-I directly in ...... beta aggregation and toxicity
@en-gb
Apolipoprotein A-I directly in ...... beta aggregation and toxicity
@nl
type
label
Apolipoprotein A-I directly in ...... beta aggregation and toxicity
@ast
Apolipoprotein A-I directly in ...... beta aggregation and toxicity
@en
Apolipoprotein A-I directly in ...... beta aggregation and toxicity
@en-gb
Apolipoprotein A-I directly in ...... beta aggregation and toxicity
@nl
prefLabel
Apolipoprotein A-I directly in ...... beta aggregation and toxicity
@ast
Apolipoprotein A-I directly in ...... beta aggregation and toxicity
@en
Apolipoprotein A-I directly in ...... beta aggregation and toxicity
@en-gb
Apolipoprotein A-I directly in ...... beta aggregation and toxicity
@nl
P2093
P356
P1433
P1476
Apolipoprotein A-I directly in ...... beta aggregation and toxicity
@en
P2093
I M Lefterov
M I Lefterova
P304
P356
10.1021/BI002186K
P407
P577
2001-03-01T00:00:00Z